I: Considerations 1. History of Liver and Multivisceral Transplantation 2. Surgical Anatomy of the Liver 3. Molecular and Cellular Basics of Hepatic Failure 4. Influence of Transplantation on Liver Surgery 5. Liver Allocation: The US Model 6. Liver Allocation: The European Models 7. Donation After Brain Death or Cardiac Death: Regulatory and Ethical Principles II: Patient Evaluation: Adult 8. Current Indications, Contraindications, De-listing Criteria and Timing for Transplantation 9. Transplantation for Hepatitis A and B 10. Natural History of Hepatitis C 11. Hepatitis C and Transplantation 12. Transplantation for Fulminant Hepatic Failure 13. Transplantation for Primary Biliary Cirrhosis 14. Transplantation for Sclerosing Cholangitis 15. Transplantation for Autoimmune Hepatitis 16. Transplantation for Hepatocellular Carcinoma 17. Transplantation for Cholangiocarcinoma 18. Transplantation for Metastases of the Liver 19. Transplantation for Hematological Disorders 20. Transplantation for Budd-Chiari Syndrome 21. Transplantation for Alcoholic Liver Disease 22. Transplantation for NASH 23. Unusual Indications for Transplantation III: Patient Evaluation: Pediatric 24. General Criteria for Pediatric Transplantation 25. Transplantation for Cholestatic Liver Disease 26. Transplantation for Biliary Atresia 27. Transplantation for Metabolic Disease 28. Transplantation for Hepatic Malignancy IV: Special Considerations in Patient Evaluation 29. Ethical Decisions in Transplantation 30. The Psychiatric Assessment of Liver Transplant Candidates 31. Pretransplantation Evaluation: Cardiac 32. Pretransplantation Evaluation: Renal 33. Pretransplantation Infectious Disease Screening for Candidates and Donors 34. Clinical Nurse Coordinator: Nursing Focus on Care of Patients with End-Stage Liver Disease 35. Radiologic Evaluation in the Transplant Patient 36. Monitoring and Care of the Patient Before Transplantation 37. Nutritional Aspects of Adult Transplantation 38. Management of Portal Hypertensive Hemorrhage 39. Portopulmonary Hypertension and Hepatopulmonary Syndrome V: Operation 40. Donor Selection and Management 41. Extended Criteria Donors 42. Non-Heart Beating Donors 43. Donor Operations 44. Principles of Preservation 45. Recipient Hepatectomy and Grafting 46. Anesthesia for Transplantation VI: Split and Living Donor Transplantation 47. Imaging Techniques for Partial Grafting 48. Living Related Transplantation in Pediatric Recipients 49. Donor and Recipient Evaluation and Selection for Adult-to-Adult Transplantation 50. Adult Living Donor Right Hepatectomy and Recipient Operation 51. Adult Living Donor Left Hepatectomy and Recipient Operation 52. Split Liver Transplantation for the Pediatric and Adult Recipients 53. Split Liver Transplantation for Two Adults 54. Best Techniques for Biliary and Vascular Reconstruction in Living Donor Transplantation 55. Small for Size Syndrome 56. Minimally Invasive Living Donor Hepatectomy 57. Dual Grafts for Transplantation 58. Outcomes of Living Donor Transplantation: Western Perspective 59. Outcomes of Living Donor Transplantation: Eastern Perspective 60. Ethics of Living Donor Transplantation VII: Unusual Operative Problems 61. Arterial Reconstructions - Pitfalls 62. Portal Vein Thrombosis and Other Venous Anomalies in Liver Transplantation 63. Combined Liver-Kidney Transplantation 64. Retransplantation 65. Clinical Management of Necrotic Liver During Transplantation 66. Transplantation with Digestive Organs 67. Transplantation and Situs Inversus 68. Auxiliary Transplants VIII: Postoperative Care 69. Postoperative Intensive Care Management in Adults 70. Postoperative Intensive Care Management in Children 71. Postoperative Management Beyond the Intensive Care Unit: Adults 72. Postoperative Care of Pediatric Transplant Recipients 73. Transition of Pediatric Patients to Adulthood 74. Renal Failure in Adult Transplant Recipients 75. Graft Failure: Etiology, Recognition, and Treatment 76. Technical Problems: Biliary 77. Management of Arterial Complications after Transplantation 78. Infections After Transplantation 79. Recurrent Hepatitis C 80. Late Complications and Recurrence of Disease 81. Neuropsychiatric Outcomes in Recipients 82. Postoperative Neurological Disorders and Prognosis 83. Role of the Posttransplantation Coordinator IX: Transplant Pathology 84. Histological Patterns of Rejection and Other Causes of Dysfunction 85. Pathology of Recurrence of Non-Neoplastic Disease After Transplantation 86. Transplant Related Malignancies X: Immunology of Liver Transplantation 87. Rejection After Transplantation 88. Cell Migration, Chimerism, and Graft Acceptance 89. ABO, Tissue Typing, and Crossmatching Incompatibility 90. GVHD after Transplantation XI: Immunosuppression 91. Induction and Maintenance of Immunosuppression 92. Special Considerations for Pediatric Immunosuppression After Transplantation 93. Treatment of Acute and Chronic Rejection 94. Novel Immunosuppression of Patients with Hepatic Malignancies 95. Non-Biologic New Immunosuppressive Drugs 96. Immunosuppressive Biologic Agents 97. Long-term Toxicity of Immunosuppressive Therapy XII: Survival and Results 98. Outcome Predictors in Transplantation 99. U.S. Trends in Transplantation: 1988-Present 100. Long-term Functional Recovery and Quality of Life: Childhood, Adulthood, Employment, Pregnancy, and Family Planning 101. Results: Survival and Quality of Life after Transplantation in Children XIII: Future Developments in Liver Transplantation 102. Genetic and Genomic Potentials in Transplantation 103. Xenotransplantation 104. Hepatocyte Transplantation 105. Stem Cell and Liver Regeneration 106. Ischemia-Reperfusion Injury 107. Extracorporeal Perfusion for Resuscitation of Marginal Grafts 108. Extracorporeal Xenogeneic Support 109. Development of Bioartificial Liver